QIAGEN N.V. is a company organized under the laws of the Netherlands and is listed on Nasdaq and in the Prime Standard Segment of the Frankfurt Stock Exchange in Germany. As such, the Company is subject to laws, rules and regulations including such of the Netherlands, the United States of America and Germany.
QIAGEN has always placed the highest standards on its corporate governance principles. Since 1997, QIAGEN has endorsed the 40 recommendations
made in the report of the Netherlands Committee on Corporate Governance, which was replaced by the Dutch Corporate Governance Code
on the 1st of January 2004. It is the Company's policy to follow the guidelines for Good Practice of Corporate Governance as described in this Code although some minor deviations may result from effects such as legal requirements imposed on QIAGEN or industry standards.
QIAGEN also is subject to the rules regarding corporate governance set by Nasdaq
, where the Company's shares have been listed since 1996.
Corporate Governance Report
Policy Regarding Bilateral Contacts with Shareholders
Adopted on December 3, 2009
View Policy (PDF)
2014 Stock Plan
On June 25, 2014, the Annual General Meeting of Shareholders approved our 2014 Stock Plan
(the “Amended Plan”) which amends and restates in its entirety our Amended and Restated 2005 Stock Plan.
Pursuant to the 2014 Stock Plan, options to purchase our Common Shares and other types of equity-based awards may be granted to employees and consultants of QIAGEN and its subsidiaries and to Supervisory Directors.
QIAGEN N.V. Insider Trading Policy
QIAGEN has established an Insider Trading Policy
which is applicable for the directors, officers and employees worldwide and which QIAGEN has undertaken to publish on the Internet pursuant to the Declaration of Corporate Governance.
QIAGEN N.V. Remuneration Report by the Compensation Committee
The Remuneration Report by the Compensation Committee
describes the way QIAGEN’s Remuneration Policy was carried out in 2015. The Remuneration Report also provides an outlook of the proposed Remuneration Policy for 2016 and the following years.
QIAGEN N.V. Charter Governing the Internal Organisation of the Supervisory Board of QIAGEN N.V.
The Charter Governing the Internal Organisation of the Supervisory Board of QIAGEN N.V.
has been updated at the meeting of the Supervisory Board of the Company on April 23, 2016.
QIAGEN N.V. Charter Governing the Supervisory Board's Compensation Committee
The Charter Governing the Supervisory Board's Compensation Committee
was updated on July 24, 2014 on the basis of article 11 of the charter of the Supervisory Board.
QIAGEN N.V. Audit Committee Charter
The Audit Committee Charter
considers the current corporate governance guidance as mandated or proposed under the Sarbanes-Oxley Act of 2002 (the “Act”), the corporate governance principles of The Netherlands and the NASDAQ Corporate Governance Proposals as of October 10, 2002 (the “Codes”).
QIAGEN N.V. Charter Governing the Supervisory Board's Selection and Appointment Committee
The Charter Governing the Supervisory Board's Selection and Appointment Committee
was prepared on April 26, 2005 on the basis of article 12.1. of the charter of the Supervisory Board.
QIAGEN N.V. Charter Governing the Supervisory Board's Science and Technology Committee
The Science and Technology Committee Charter
has been adopted on July 24, 2014 on the basis of article 12a of the Charter of the Supervisory Board.
QIAGEN N.V. Articles of Association dated June 2011
The Articles of Association
were prepared on June 30, 2011
The english version is an unofficial translation from the dutch Articles of Association.